The industry might consider coordinating an effort to prevent advisory committees from using outcomes as tools to present one-sided versions of price negotiations. …
If this does signal a new way of communicating, the industry has tools to deploy
July 9, 2024 Latest NewsBioPharmaComment
Latest Video
Georgia Forrest
New Stories
-
Sandoz adds to vision care options with the listing of biosimilar aflibercept
February 2, 2026 - -
PYC’s capital raise marks one of the largest biotech fundraisings in Australian market history
February 2, 2026 - - Australian Biotech -
Genetic Signatures appoints seasoned life sciences executive as CEO
February 2, 2026 - - Australian Biotech -
EMA decision clears regulatory path for Argenica’s lead stroke drug in Europe
February 2, 2026 - - Australian Biotech -
Recce Pharmaceuticals deepens US partnership to advance burn wound treatment
February 2, 2026 - - Australian Biotech -
Another potential turning point for immunotherapy access in Australia
February 1, 2026 - - Latest News -
An announcement that cost more than the listing, because it would have actually cost something
February 1, 2026 - - Latest News